ArticleGut and liver2021

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?

Jihye Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.